author-photo

Hiroki Masuda

Chiba University

52

Papers

322

Citations

Citation Trend

Filter By

Papers (34) Sort By

Journal Conference Others

Remyelination and neuroprotective effects of alemtuzumab therapy in patients with multiple sclerosis

2021 Journal of Neurology, Neurosurgery, and Psychiatry
Show All
- Source
- Cite
- Save
Citations (0)
AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders.

2021
Show All
- Source
- Cite
- Save
Citations (2)
Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany.

2020 Journal of Neurology, Neurosurgery, and Psychiatry
Show All
- Source
- Cite
- Save
Citations (8)
Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder

2020
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of brain atrophy in multiple sclerosis patients treated with first generation disease modifying therapy without clinical relapse

2020 European Journal of Neurology
Show All
- Source
- Cite
- Save
Citations (1)
Relapse numbers and earlier intervention by disease modifying drugs are related with progression of less brain atrophy in patients with multiple sclerosis

2019 Journal of the Neurological Sciences
Show All
- Source
- Cite
- Save
Citations (5)
Peripheral blood helper T cell profiles and their clinical relevance in MOG-IgG-associated and AQP4-IgG-associated disorders and MS

2019 Journal of Neurology, Neurosurgery, and Psychiatry
Show All
- Source
- Cite
- Save
Citations (8)
Soluble CD40 ligand disrupts the blood–brain barrier and exacerbates inflammation in experimental autoimmune encephalomyelitis

2018 Journal of Neuroimmunology
Show All
- Source
- Cite
- Save
Citations (6)
Validation of the Modified Fatigue Impact Scale and the relationships among fatigue, pain and serum interleukin-6 levels in patients with neuromyelitis optica spectrum disorder

2018 Journal of the Neurological Sciences
Show All
- Source
- Cite
- Save
Citations (6)
Risk factors for fingolimod-induced lymphopenia in multiple sclerosis:

2018
Show All
- Source
- Cite
- Save
Citations (12)